These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36163589)

  • 1. Nonalcoholic fatty liver disease in relation to the remission and progression along the glycemic continuum.
    Xin Z; Huang J; Cao Q; Wang J; He R; Hou T; Ding Y; Lu J; Xu M; Wang T; Zhao Z; Wang W; Ning G; Bi Y; Xu Y; Li M
    J Diabetes; 2022 Sep; 14(9):606-619. PubMed ID: 36163589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals.
    Wang B; Li M; Zhao Z; Wang S; Lu J; Chen Y; Xu M; Wang W; Ning G; Bi Y; Wang T; Xu Y
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32144419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population.
    Li CH; Chou YT; Shen WC; Lu FH; Yang YC; Wu JS; Chang CJ
    J Diabetes Investig; 2020 Sep; 11(5):1336-1343. PubMed ID: 32270583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabesity phenotype in relation to the incidence and resolution of nonalcoholic fatty liver disease: A prospective cohort study.
    Kong L; Ye C; Wang Y; Dou C; Zheng J; Wang S; Lin H; Zhao Z; Li M; Xu Y; Chen Y; Lu J; Xu M; Wang W; Ning G; Bi Y; Wang T
    J Diabetes; 2024 Jan; 16(1):e13459. PubMed ID: 37584361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.
    Nobili V; Mantovani A; Cianfarani S; Alisi A; Mosca A; Sartorelli MR; Maffeis C; Loomba R; Byrne CD; Targher G
    J Hepatol; 2019 Oct; 71(4):802-810. PubMed ID: 31279904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean and visit-to-visit variability of glycated hemoglobin, and the risk of non-alcoholic fatty liver disease.
    Yoo JH; Kang M; Kim G; Hur KY; Kim JH; Sinn DH; Jin SM
    J Diabetes Investig; 2021 Jul; 12(7):1252-1262. PubMed ID: 33135331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.
    Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q
    Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.
    Li M; Zhao Z; Qin G; Chen L; Lu J; Huo Y; Chen L; Zeng T; Xu M; Chen Y; Wang T; Wang S; Xu Y; Shi L; Tang X; Su Q; Yu X; Yan L; Wan Q; Chen G; Gao Z; Wang G; Shen F; Luo Z; Zhang Y; Liu C; Wang Y; Hu R; Ye Z; Wu S; Deng H; Yang T; Li Q; Qin Y; Mu Y; Zhao J; Ning G; Bi Y; Xu Y; Wang W
    Metabolism; 2021 Nov; 124():154874. PubMed ID: 34517014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes.
    Xie Y; Kong W; Wang X; Wu Z
    BMC Endocr Disord; 2022 Aug; 22(1):220. PubMed ID: 36045348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.
    Newton KP; Hou J; Crimmins NA; Lavine JE; Barlow SE; Xanthakos SA; Africa J; Behling C; Donithan M; Clark JM; Schwimmer JB;
    JAMA Pediatr; 2016 Oct; 170(10):e161971. PubMed ID: 27478956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelation of the Risk Factors of NAFLD at various Stages of Progression of the glycemic Status on long-term Follow-up.
    Ray G; Kumar C
    J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).
    Ortiz-Lopez C; Lomonaco R; Orsak B; Finch J; Chang Z; Kochunov VG; Hardies J; Cusi K
    Diabetes Care; 2012 Apr; 35(4):873-8. PubMed ID: 22374640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial.
    Guo W; Tian W; Lin L; Xu X
    Diabetes Res Clin Pract; 2020 Dec; 170():108487. PubMed ID: 33035599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-Hour Postload Hyperglycemia Confers Higher Risk of Hepatic Steatosis to HbA1c-Defined Prediabetic Subjects.
    Fiorentino TV; Andreozzi F; Mannino GC; Pedace E; Perticone M; Sciacqua A; Perticone F; Sesti G
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4030-4038. PubMed ID: 27459528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bidirectional relationship between NAFLD and type 2 diabetes: A prospective population-based cohort study.
    Wang M; Zhao Y; He Y; Zhang L; Liu J; Zheng S; Bai Y
    Nutr Metab Cardiovasc Dis; 2023 Aug; 33(8):1521-1528. PubMed ID: 37336719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-specific differences in prevalence of nonalcoholic fatty liver disease in subjects with prediabetes and type 2 diabetes.
    Succurro E; Marini MA; Fiorentino TV; Perticone M; Sciacqua A; Andreozzi F; Sesti G
    Diabetes Res Clin Pract; 2022 Aug; 190():110027. PubMed ID: 35917992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study.
    Mantovani A; Taverna A; Cappelli D; Beatrice G; Csermely A; Sani E; Byrne CD; Targher G
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults.
    Zhang J; Xu Q; Lai F; Chen N; Lin M; Liu Y; Zhang W; Liu C; Wang S; Li Z
    BMJ Open Diabetes Res Care; 2021 Aug; 9(1):. PubMed ID: 34433546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease.
    Ng CH; Chan KE; Chin YH; Zeng RW; Tsai PC; Lim WH; Tan DJH; Khoo CM; Goh LH; Ling ZJ; Kulkarni A; Mak LL; Huang DQ; Chan M; Chew NW; Siddiqui MS; Sanyal AJ; Muthiah M
    Clin Mol Hepatol; 2022 Jul; 28(3):565-574. PubMed ID: 35585687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.